Carlsmed, Inc. (CARL)
NasdaqGS · USD · Healthcare · Health Information Services
$15.10 (+1.27%) as of
Key statistics
- Market cap
- 412.27M
- Forward P/E
- -10.94
- EPS (TTM)
- -1.08
- Dividend yield
- 0.00%
- 52-week range
- 8.50 – 17.23
- Revenue (TTM)
- 63.3M
- Profit margin
- -57.42%
- Analyst target
- $19.40
- Volume
- 19.88k
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Carlsbad, CA, United States
- Employees
- 127
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.